(Q35332522)

7 August 2017

1 reference

title

Tropisetron. A review of the clinical experience (English)

1 reference

7 August 2017

de Bruijn KM

1

1 reference

7 August 2017

K. M. de Bruijn

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1380428

20 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1380428

20 September 2022

publication date

1 January 1992

1 reference

7 August 2017

1 reference

7 August 2017

volume

43 Suppl 3

1 reference

7 August 2017

page(s)

11-22

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199200433-00005

7 August 2017

exact match

0 references

cites work

Extrapyramidal reactions with high-dose metoclopramide

1 reference

12 December 2020

Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy

1 reference

12 December 2020

Compassionate use of a 5-HT3-receptor antagonist, tropisetron, in patients refractory to standard antiemetic treatment

1 reference

12 December 2020

Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapy

1 reference

12 December 2020

The effect of three dose levels of ICS 205-930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomiting.

1 reference

12 December 2020

Tropisetron, a new 5-HT3-receptor antagonist, in the prevention of radiation-induced nausea, vomiting and diarrhoea

1 reference

12 December 2020

A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen

1 reference

12 December 2020

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

1 reference

12 December 2020

Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy

1 reference

12 December 2020

Neuropharmacology of emesis induced by anti-cancer therapy.

1 reference

12 December 2020

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial

1 reference

12 December 2020

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 reference

12 December 2020

Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients

1 reference

12 December 2020

First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis

1 reference

12 December 2020

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

1 reference

12 December 2020

10.2165/00003495-199200433-00005

Identifiers

DOI

0 references

Dimensions Publication ID

1040103387

0 references

1 reference